Blood Res.  2016 Jun;51(2):127-132. 10.5045/br.2016.51.2.127.

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma

  • 1Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
  • 2Department of Laboratory Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
  • 3Department of Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.


A high Ki-67 proliferation index (PI) in neoplastic cells is associated with poor survival in mantle cell lymphoma (MCL). We aimed to determine the cut-off values for the Ki-67 PI as a prognostic factor in MCL according to bone marrow findings.
Immunohistochemical (IHC) staining for Ki-67 was performed on formalin-fixed paraffin-embedded biopsy tissues from 56 patients with MCL. Patients were grouped based on their Ki-67 PI values. Survival analyses were carried out and the cut-off value for the Ki-67 PI was determined.
Of the 56 patients, 39 (69.6%) showed bone marrow involvement of MCL; 21 of these patients had leukemic manifestations at the time of diagnosis. The results of the Ki-67 IHC staining were as follows: ≤10% in 22 patients, 11-20% in 14 patients, 21-30% in 3 patients, 31-40% in 4 patients, 41-50% in 4 patients, and >50% in 9 patients. A cut-off value of 20% revealed significantly different survival rates with mean survival times of 69.8 months (Ki-67 PI≤20%) and 47.9 months (Ki-67 PI>20%), irrespective of bone marrow findings (P=0.034). Clinical outcomes did not differ, regardless of bone marrow findings. However, in cases with bone marrow involvement, the Ki-67 cut-off value of 30% for overall survival was required to yield statistical significance (P=0.033).
The 20% cut-off value for the Ki-67 PI was clinically meaningful, regardless of bone marrow involvement of MCL. For patients with bone marrow involvement, the statistically significant cut-off value increased to 30%.


Bone marrow; Ki-67 proliferation index; Mantle cell lymphoma; Prognosis

MeSH Terms

Bone Marrow
Lymphoma, Mantle-Cell*
Survival Rate
Full Text Links
  • BR
export Copy
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error